Lv3
294 积分 2023-11-28 加入
Induction chemotherapy plus concomitant chemoradiotherapy in nasopharyngeal carcinoma: An updated network meta-analysis
1小时前
待确认
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
4天前
已完结
Immune checkpoint inhibitor combined with chemotherapy versus chemotherapy alone in the first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis of random controlled trials
11天前
已完结
The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis
11天前
已完结
Outcomes for the treatment of locoregional recurrent nasopharyngeal cancer: Systematic review and pooled analysis
11天前
已完结
ESMO–EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease
11天前
已完结
Efficacy and Safety of Cell-based Immunotherapy in The Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma – A Systematic Review and Meta-analysis
11天前
已完结
Postmastectomy radiotherapy indications using pathological prognostic staging in node-positive breast cancer
17天前
已关闭
Sequential vs Induction Plus Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma
17天前
已完结
Optimal induction chemotherapy courses in nasopharyngeal carcinoma in the IMRT era: A recursive partitioning risk stratification analysis based on EBV DNA and AJCC staging
1个月前
已完结
皖公网安备34019202002308
